Skip to main content
AAN.com
Brief Communications
September 24, 2002

Ullrich disease: Collagen VI deficiency: EM suggests a new basis for muscular weakness

September 24, 2002 issue
59 (6) 920-923

Abstract

Ullrich disease is a form of congenital muscular dystrophy characterized clinically by generalized muscle weakness, contractures of the proximal joints, and hyperflexibility of the distal joints from birth or early infancy. Recently, mutations of the collagen VI gene have been associated with Ullrich disease. The authors report on a boy with Ullrich disease who has complete deficiency of collagen VI and harbors compound heterozygous mutations in the collagen VI alpha 2 gene. Absence of microfibrils on EM, together with normal collagen fibrils and basal lamina, suggests that loss of a link between interstitium and basal lamina may be a new molecular pathomechanism of muscular dystrophy.

Get full access to this article

View all available purchase options and get full access to this article.

Supplementary Material

File (neurology_figuree3.gif)

References

1.
Ullrich O. kongenitale, atonisch-sklerotische Muskeldystrophie, ein weiterer Typus der heredodegenerativen Erkrankungen des neuromuskulären Systems. Z Ges Neurol Psychiat . 1930; 126: 171–201.
2.
Nonaka I, Une Y, Ishihara T, Miyoshino S, Nakashima T, Sugita H. A clinical and histological study of Ullrich’s disease (congenital atonic-sclerotic muscular dystrophy). Neuropediatrics . 1981; 12: 197–208.
3.
Vanegas OC, Bertini E, Zhang RZ, et al. Ullrich scleroatonic muscular dystrophy is caused by recessive mutations in collagen type VI. Proc Natl Acad Sci USA . 2001; 98: 7516–7521.
4.
Higuchi I, Shiraishi T, Hashiguchi T, et al. Frameshift mutation in the collagen VI gene causes Ullrich’s disease. Ann Neurol . 2001; 50: 261–265.
5.
Pepe G, Bertini E, Giusti B, et al. A novel de novo mutation in the triple helix of the COL6A3 gene in a two-generation Italian family affected by Bethlem myopathy: a diagnostic approach in the mutations’ screening of type VI collagen. Neuromuscul Disord . 1999; 9: 264–271.
6.
Benjamin Lewin. Genes VII. Oxford: Oxford University Press, 2000.
7.
Kuo HJ, Maslen CL, Keene DR, Glanville RW. Type VI collagen anchors endothelial basement membranes by interacting with type IV collagen. J Biol Chem . 1997; 272: 26522–26529.

Information & Authors

Information

Published In

Neurology®
Volume 59Number 6September 24, 2002
Pages: 920-923
PubMed: 12297580

Publication History

Received: March 4, 2002
Accepted: May 29, 2002
Published online: September 24, 2002
Published in print: September 24, 2002

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

H. Ishikawa, MD
From the Department of Neuromuscular Research (Drs. Ishikawa, Sugie, Nishino, and Nonaka and N. Minami), National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Kodaira, Tokyo; Department of Neurology (Dr. Ishikawa), Nihon University School of Medicine, Tokyo; Department of Neurology (Dr. Sugie), Nara Medical University, Nara; Department of Pediatrics (Dr. Murayama), National Rehabilitation Center for Disabled Children, Tokyo; and Department of Pediatrics (Dr. Ito), Metropolitan Bokutoh Hospital, Tokyo, Japan.
K. Sugie, MD PhD
From the Department of Neuromuscular Research (Drs. Ishikawa, Sugie, Nishino, and Nonaka and N. Minami), National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Kodaira, Tokyo; Department of Neurology (Dr. Ishikawa), Nihon University School of Medicine, Tokyo; Department of Neurology (Dr. Sugie), Nara Medical University, Nara; Department of Pediatrics (Dr. Murayama), National Rehabilitation Center for Disabled Children, Tokyo; and Department of Pediatrics (Dr. Ito), Metropolitan Bokutoh Hospital, Tokyo, Japan.
K. Murayama, MD
From the Department of Neuromuscular Research (Drs. Ishikawa, Sugie, Nishino, and Nonaka and N. Minami), National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Kodaira, Tokyo; Department of Neurology (Dr. Ishikawa), Nihon University School of Medicine, Tokyo; Department of Neurology (Dr. Sugie), Nara Medical University, Nara; Department of Pediatrics (Dr. Murayama), National Rehabilitation Center for Disabled Children, Tokyo; and Department of Pediatrics (Dr. Ito), Metropolitan Bokutoh Hospital, Tokyo, Japan.
M. Ito, MD
From the Department of Neuromuscular Research (Drs. Ishikawa, Sugie, Nishino, and Nonaka and N. Minami), National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Kodaira, Tokyo; Department of Neurology (Dr. Ishikawa), Nihon University School of Medicine, Tokyo; Department of Neurology (Dr. Sugie), Nara Medical University, Nara; Department of Pediatrics (Dr. Murayama), National Rehabilitation Center for Disabled Children, Tokyo; and Department of Pediatrics (Dr. Ito), Metropolitan Bokutoh Hospital, Tokyo, Japan.
N. Minami, MS
From the Department of Neuromuscular Research (Drs. Ishikawa, Sugie, Nishino, and Nonaka and N. Minami), National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Kodaira, Tokyo; Department of Neurology (Dr. Ishikawa), Nihon University School of Medicine, Tokyo; Department of Neurology (Dr. Sugie), Nara Medical University, Nara; Department of Pediatrics (Dr. Murayama), National Rehabilitation Center for Disabled Children, Tokyo; and Department of Pediatrics (Dr. Ito), Metropolitan Bokutoh Hospital, Tokyo, Japan.
I. Nishino, MD PhD
From the Department of Neuromuscular Research (Drs. Ishikawa, Sugie, Nishino, and Nonaka and N. Minami), National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Kodaira, Tokyo; Department of Neurology (Dr. Ishikawa), Nihon University School of Medicine, Tokyo; Department of Neurology (Dr. Sugie), Nara Medical University, Nara; Department of Pediatrics (Dr. Murayama), National Rehabilitation Center for Disabled Children, Tokyo; and Department of Pediatrics (Dr. Ito), Metropolitan Bokutoh Hospital, Tokyo, Japan.
I. Nonaka, MD PhD
From the Department of Neuromuscular Research (Drs. Ishikawa, Sugie, Nishino, and Nonaka and N. Minami), National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Kodaira, Tokyo; Department of Neurology (Dr. Ishikawa), Nihon University School of Medicine, Tokyo; Department of Neurology (Dr. Sugie), Nara Medical University, Nara; Department of Pediatrics (Dr. Murayama), National Rehabilitation Center for Disabled Children, Tokyo; and Department of Pediatrics (Dr. Ito), Metropolitan Bokutoh Hospital, Tokyo, Japan.

Notes

Address correspondence and reprint requests to Dr. Ichizo Nishino, Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), 4-1-1 Ogawahigashi-cho, Kodaira, Tokyo 187-8502, Japan; e-mail: [email protected]

Metrics & Citations

Metrics

Citation information is sourced from Crossref Cited-by service.

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Orthopedic manifestations of congenital muscular dystrophy subtypes in children: Emerging signatures need consolidation: a scoping review, Journal of Musculoskeletal Surgery and Research, 8, (11-23), (2024).https://doi.org/10.25259/JMSR_229_2023
    Crossref
  2. Autosomal Dominant Limb-Girdle Muscular Dystrophies, Principles and Practice of the Muscular Dystrophies, (73-91), (2024).https://doi.org/10.1007/978-3-031-44009-0_5
    Crossref
  3. Extracellular Matrix Disorganization and Sarcolemmal Alterations in COL6-Related Myopathy Patients with New Variants of COL6 Genes, International Journal of Molecular Sciences, 24, 6, (5551), (2023).https://doi.org/10.3390/ijms24065551
    Crossref
  4. Childhood muscular dystrophies, Motor System Disorders, Part I: Normal Physiology and Function and Neuromuscular Disorders, (461-496), (2023).https://doi.org/10.1016/B978-0-323-98818-6.00024-8
    Crossref
  5. P4HA1 Regulates CD31 via COL6A1 in the Transition of Glioblastoma Stem-Like Cells to Tumor Endothelioid Cells, Frontiers in Oncology, 12, (2022).https://doi.org/10.3389/fonc.2022.836511
    Crossref
  6. Surgical treatment of scoliosis in Ullrich Congenital Muscular Dystrophy: a case series of 3 patients., Intractable & Rare Diseases Research, 10, 2, (75-80), (2021).https://doi.org/10.5582/irdr.2020.03162
    Crossref
  7. Collagen VI as a driver and disease biomarker in human fibrosis, The FEBS Journal, 289, 13, (3603-3629), (2021).https://doi.org/10.1111/febs.16039
    Crossref
  8. Muscular Dystrophies and Allied Disorders III, Muscle Biopsy, (261-285), (2021).https://doi.org/10.1016/B978-0-7020-7471-4.00012-4
    Crossref
  9. Collagens and Muscle Diseases: A Focus on Collagen VI, The Collagen Superfamily and Collagenopathies, (199-256), (2021).https://doi.org/10.1007/978-3-030-67592-9_6
    Crossref
  10. The Hypotonic Infant, Fenichel's Clinical Pediatric Neurology, (150-171), (2019).https://doi.org/10.1016/B978-0-323-48528-9.00006-6
    Crossref
  11. See more
Loading...

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Media

Figures

Other

Tables

Share

Share

Share article link

Share